Advances in pediatric asthma in 2007

Journal of Allergy and Clinical Immunology

Volumn 121, Issue 3, 2008, Pages 614-619

  Szefler, Stanley J ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Asthma; asthma control; asthma impairment; asthma risk; asthma severity; biomarkers; early intervention in asthma; therapeutics

Indexed keywords

BCG VACCINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FOOD ALLERGEN; HOUSE DUST ALLERGEN; MONTELUKAST; NITRIC OXIDE; PREDNISOLONE;

ASTHMA; CHILD CARE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; EXERCISE INDUCED ASTHMA; HUMAN; LOW DRUG DOSE; MONOTHERAPY; PHENOTYPE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; TREATMENT RESPONSE; VIRAL RESPIRATORY TRACT INFECTION; WHEEZING;

ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CLINICAL TRIALS AS TOPIC; GUIDELINES AS TOPIC; HUMANS;

EID: 40049094542     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.11.033     Document Type: Review

References (57)

1. Szefler S.J. Advances in pediatric asthma. J Allergy Clin Immunol 117 (2007) 512-518
2. 2007 GINA Report: Global Strategy for Asthma Management and Prevention. Available at: http://www.ginasthma.org. Accessed December 30, 2007.
3. National Institutes of Health. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 3: guidelines for the diagnosis and management of asthma. August 2007. NIH publication no. 07-4051. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/index.htm. Accessed December 30, 2007.
4. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 120 (2007) S94-S138
5. Busse W.W., and Lemanske R.F. Expert Panel Report 3: moving forward to improve asthma care. J Allergy Clin Immunol 120 (2007) 1012-1014
6. Kelly H.W. Rationale for the major changes in the pharmacotherapy section of the National Asthma and Education Program Guidelines. J Allergy Clin Immunol 120 (2007) 989-994
7. Stoloff S.W. Implications of the asthma guidelines for the clinician. J Allergy Clin Immunol 120 (2007) 1021-1022
8. De Blic J., and Scheinmann P. The use of imaging techniques for assessing severe childhood asthma. J Allergy Clin Immunol 119 (2007) 808-810
9. Liu A.H., Zeiger R., Sorkness C., Mahr T., Ostrom N., Burgess S., et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 119 (2007) 817-825
10. Strunk R.C. Childhood Asthma Management Program: lessons learned. J Allergy Clin Immunol 119 (2007) 36-42
11. Strunk R.C., Weiss S.T., Yates K.P., Tonascia J., Zeiger R.S., Szefler S.J., and CAMP Research Group. Mild to moderate asthma affects lung growth in children and adolescents. J Allergy Clin Immunol 118 (2006) 1040-1047
12. Van Gant R., van der Ent C.K., Rovers M.M., Kimpen J.L.L., ven Essen-Zandvliet L.E.M., and de Meer G. Excessive body weight is associated with additional loss of quality of life in children with asthma. J Allergy Clin Immunol 119 (2007) 591-596
13. Cazzoletti L., Marcon A., Janson C., Corsico A., Jarvis D., Pin I., et al. Asthma control in Europe: a real world evaluation based on an international population-based study. J Allergy Clin Immunol 120 (2007) 1360-1367
14. Federico M.J., Wamboldt F.S., Carter R., Mansell A., and Wamboldt M.Z. History of serious asthma exacerbations should be included in guidelines of asthma severity. J Allergy Clin Immunol 119 (2007) 50-56
15. Tantisira K., Silverman E., Mariani T., Xu J., Richter B., Klanderman B., et al. FCER2: A pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol 120 (2007) 1285-1291
16. Sorkness C.A., Lemanske Jr. R.F., Mauger D.T., Boehmer S.J., Chinchili V.M., Matinez F.D., et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 119 (2007) 64-72
17. Denlinger L.C., Sorkness C.A., Chinchilli V.M., and Lemanske R.F. Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network. J Allergy Clin Immunol 119 (2007) 3-11
18. Martin R.J., Szefler S.J., King T.S., Kraft M., Boushey H.A., Chinchilli V.M., et al. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 119 (2007) 73-80
19. Szefler S.J., Phillips B.R., Martinez F.D., Chinchilli V.M., Lemanske R.F., Strunk R.C., et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 115 (2005) 233-242
20. Gibson P.G., Powell H.P., and Ducharme F.M. Differential effects of long-acting β-agonist and inhaled corticosteroid on asthma control and asthma exacerbations. J Allergy Clin Immunol 119 (2007) 344-350
21. Pedersen S.E., Bateman E.D., Bousquet J., Busse W.W., Yoxall S., Clark T.J., et al. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study. J Allergy Clin Immunol 120 (2007) 1036-1042
22. Martinez F. Asthma treatment and asthma prevention: a tale of 2 parallel pathways. J Allergy Clin Immunol 119 (2007) 30-33
23. Stern D.A., Morgan W.J., Wright A.L., Guerra S., and Martinez F.D. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 370 (2007) 758-764
24. Bisgaard H., Hermansen M.N., Buchvald F., Loland L., Halkjaer L.B., Bonnelykke K., et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 357 (2007) 1487-1495
25. Scirica C.V., Gold D.R., Ryan L., Abulkerim H., Celedon J.C., Platts-Mills T.A.E., et al. Predictors of cord blood IgE levels in children at risk for asthma and atopy. J Allergy Clin Immunol 119 (2007) 81-88
26. Szefler S.J., Baker J.W., Uryniak T., Goldman M., and Silkoff P.E. Comparative study of budesonide and montelukast in young children with mild persistent asthma. J Allergy Clin Immunol 120 (2007) 1043-1050
27. Arshad S.H., Bateman B., Sadeghnejad A., Gant C., and Matthews S.M. Prevention of allergic disease during childhood by allergen avoidance: the Isle of Wright prevention study. J Allergy Clin Immunol 119 (2007) 307-313
28. Mandhane P.J., Greene J.M., Sys D.C., and Sears M.R. Interactions between breast-feeding, specific parental atopy, and sex on development of asthma and allergy. J Allergy Clin Immunol 119 (2007) 1359-1366
29. Chan-Yeung M., Dimich-Ward H., and Becker A. Atopy in early life and effect of a primary prevention program for asthma in a high-risk cohort. J Allergy Clin Immunol 120 (2007) 1221-1223
30. Linehan M.F., Frank T.L., Hazell M.L., Francis H.C., Morris J.A., Baxter D.N., et al. Is the prevalence of wheeze in children altered by neonatal BCG vaccination?. J Allergy Clin Immunol 119 (2007) 1079-1085
31. Lehtinen P., Ruohola A., Vanto T., Vuorinen T., Ruuskanen O., and Jartti T. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J Allergy Clin Immunol 119 (2007) 570-575
32. Weinberger M. Should corticosteroids be used for first-time young wheezers?. J Allergy Clin Immunol 119 (2007) 567-569
33. Busse W.W., and Mitchell H. Addressing issues of asthma in inner city children. J Alergy Clin Immunol 119 (2007) 43-49
34. Jones C.A., Clement L.T., Morphew T., Kwong K.Y.C., Hanley-Lopez J., Lifson F., et al. Achieving and maintaining asthma control in an urban pediatric disease management program: the Breathmobile Program. J Allergy Clin Immunol 119 (2007) 1445-1453
35. Oryszczyn M.-P., Bouzigon E., Maccario J., Siroux V., Nadif R., Wright A., et al. Interrelationships of quantitative asthma-related phenotypes in the Epidemiological Study on the Genetics and Environment of Asthma, Bronchial Hyperresponsiveness, and Atopy. J Allergy Clin Immunol 119 (2007) 57-63
36. Bacharier L.B., Phillips B.R., Bloomberg G.R., Zeiger R.S., Paul I.M., Krawiec M., et al. Severe intermittent wheezing in preschool children: a distinct phenotype. J Allergy Clin Immunol 119 (2007) 604-610
37. Chipps B.E., Szefler S.J., Simons F.E.R., Haselkorn T., Mink D.R., Deniz Y., et al. Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma. J Asthma Clin Immunol 119 (2007) 1156-1163
38. Weiler J.M., Bonini S., Coifman R., Craig T., Delgado L., Capao-Filipe M., et al. American Academy of Allergy, Asthma & Immunology Work Group Report: exercise-induced asthma. J Allergy Clin Immunol 119 (2007) 1349-1358
39. Khetsuriani N., Kazerouni N.N., Erdman D.D., Lu X., Redd S.C., Anderson L.J., et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol 119 (2007) 314-321
40. Apter A.J., and Szefler S.J. Advances in adult and pediatric asthma. J Allergy Clin Immunol 117 (2006) 512-518
41. Szefler S.J. A view from the bus: on the roadmap with the National Institutes of Health Asthma Networks. J Allergy Clin Immunol 119 (2007) 24-27
42. Drazen J.M., Lenfant C., and Hurd S.S. Acorns and inhalers: the Asthma Clinical Research Network. J Allergy Clin Immunol 119 (2007) 28-29
43. Wu A.C., Paltiel A.D., Kuntz K.M., Weiss S.T., and Fuhlbrigge A.L. Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model. J Allergy Clin Immunol 120 (2007) 1146-1152
44. Krishnan J.A., and Gould M. Omalizumab for severe allergic asthma: dollars and sense. J Allergy Clin Immunol 120 (2007) 1015-1017
45. Pajno G.B. Sublingual immunotherapy: the optimism and the issues. J Allergy Clin Immunol 119 (2007) 796-801
46. Van der Hulst A.E., Klip H., and Brand P.L.P. Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol 120 (2007) 565-569
47. Wenzel S.E., and Busse W.W. Severe asthma: lessons from the Severe Asthma Research Program. J Allergy Clin Immunol 119 (2007) 14-21
48. Haldar P., and Pavord I.D. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol 119 (2007) 1043-1052
49. Mauad T., Bel E.H., and Sterk P.J. Asthma therapy and airway remodeling. J Allergy Clin Immunol 120 (2007) 997-1009
50. Schleimer R.P., Kato A., Kern R., Kuperman D., and Avila P. Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol 120 (2007) 1279-1284
51. Holgate S.T. Epithelium dysfunction in asthma. J Allergy Clin Immunol 120 (2007) 1233-1244
52. Chen W., and Hershey G.K. Signal transducer and activator of transcription signals in allergic disease. J Allergy Clin Immunol 119 (2007) 529-541
53. Rosenberg H.F., Phipps S., and Foster P.S. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 119 (2007) 1303-1310
54. Barnes P.J. New molecular targets for the treatment of neutrophilic diseases. J Allergy Clin Immunol 119 (2007) 1055-1062
55. Liu Y.-J. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J Allergy Clin Immunol 120 (2007) 238-244
56. Schmidt-Weber C.B., Akdis M., and Akdis C.A. Th17 cells in the big picture of immunology. J Allergy Clin Immunol 120 (2007) 247-254
57. Mai X.-M., Becker A.B., Sellars E.A.C., Liem J.J., and Kozyrskij A.L. The relationship of breast-feeding, overweight, and asthma in preadolescents. J Allergy Clin Immunol 120 (2007) 551-556